Ansag, Richelle M.

HRN: 22-00-17  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2022
CEFUROXIME 500MG (TAB)
09/29/2022
10/07/2022
PO
500mg
Q12
UTI
Waiting Final Action 
09/30/2022
CEFTRIAXONE 1G (VIAL)
09/30/2022
10/07/2022
IV
2g
OD
Pneumonia
Waiting Final Action 
10/01/2022
AZITHROMYCIN 500MG TABLET (TAB)
10/01/2022
10/05/2022
PO
500mg
OD
T/C Obstructive Pneumonia; Sepsis
Waiting Final Action 
10/01/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/01/2022
10/08/2022
IV
4.5
Q6
Sepsis; T/C Obstructive Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: